Terms: = Colorectal cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF
118 results:
1. Trends in colorectal cancer screening compliance and incidence among 60- to 74-year-olds in China.
Zhang M; Zhang Y; Guo L; Zhao L; Jing H; Yang X; Zhang W; Zhang Y; Nie Z; Zhu S; Zhang S; Zhang X
Cancer Med; 2024 Apr; 13(8):e7133. PubMed ID: 38634216
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and risk factors of colorectal neoplasia in individuals aged 40-49 years: Findings from screening program in China.
Zhang M; Zhang Y; Zhang W; Zhang Y; Zhao L; Jing H; Gao X; Nie Z; Zhu S; Zhang S; Zhang X
J Gastroenterol Hepatol; 2024 Apr; 39(4):694-700. PubMed ID: 38200678
[TBL] [Abstract] [Full Text] [Related]
3. Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon cancer Cells.
Park YR; Jee W; Park SM; Kim SW; Jung JH; Kim H; Kim KI; Jang HJ
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139419
[TBL] [Abstract] [Full Text] [Related]
4. Risk of recurrent advanced colorectal neoplasia in individuals with baseline non-advanced neoplasia followed up at 5 vs 7-10 years.
Wong MCS; Leung EY; Chun SCC; Deng Y; Lam T; Tang RSY; Huang J
J Gastroenterol Hepatol; 2023 Dec; 38(12):2122-2129. PubMed ID: 37771047
[TBL] [Abstract] [Full Text] [Related]
5. Prediction of advanced colorectal neoplasia based on metabolic parameters among symptomatic patients.
Wong MCS; Leung EY; Chun SCC; Wang HH; Huang J
J Gastroenterol Hepatol; 2023 Sep; 38(9):1576-1586. PubMed ID: 37403251
[TBL] [Abstract] [Full Text] [Related]
6. An adjusted Asia-Pacific colorectal screening score system to predict advanced colorectal neoplasia in asymptomatic Chinese patients.
Zhang C; Zhang L; Zhang W; Guan B; Li S
BMC Gastroenterol; 2023 Jun; 23(1):223. PubMed ID: 37386357
[TBL] [Abstract] [Full Text] [Related]
7. Recurrence rates of advanced colorectal neoplasia (acn) in subjects with baseline acn followed up at different surveillance intervals.
Wong MCS; Leung EY; Chun SCC; Deng Y; Lam T; Tang RSY; Huang J
Dig Liver Dis; 2023 Dec; 55(12):1742-1749. PubMed ID: 37127494
[TBL] [Abstract] [Full Text] [Related]
8. The potential effect of schisandrin-B combination with panitumumab in wild-type and mutant colorectal cancer cell lines: Role of apoptosis and autophagy.
Sana-Eldine AO; Abdelgawad HM; Kotb NS; Shehata NI
J Biochem Mol Toxicol; 2023 May; 37(5):e23324. PubMed ID: 36808796
[TBL] [Abstract] [Full Text] [Related]
9. FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective study.
Zhao S; Wang S; Pan P; Xia T; Wang R; Cai Q; Chang X; Yang F; Gu L; He Z; Wu J; Meng Q; Wang T; Fang Q; Mou X; Yu H; Zheng J; Bai C; Zou Y; Chen D; Zou X; Ren X; Xu L; Yao P; Xiong G; Shu X; Dang T; Zhang L; Wang W; Kang S; Cao H; Gong A; Li J; Zhang H; Du Y; Li Z; Bai Y;
J Hematol Oncol; 2022 Nov; 15(1):162. PubMed ID: 36333749
[TBL] [Abstract] [Full Text] [Related]
10. Head-to-head comparison of a risk-adapted screening strategy using various risk prediction models in detecting colorectal neoplasm.
Lu M; Zhang Y; Cai J; Lu B; Luo C; Chen H; Dai M
J Gastroenterol Hepatol; 2022 Jul; 37(7):1244-1252. PubMed ID: 35263809
[TBL] [Abstract] [Full Text] [Related]
11. Spectrum of Advanced colorectal Neoplasia and Anticipated Yield of Average-Risk Screening in Veterans Under Age 50.
Yen T; Scolaro J; Montminy E; Karlitz JJ; Wani S; Patel SG;
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):827-829.e3. PubMed ID: 34800736
[TBL] [Abstract] [Full Text] [Related]
12. Multivariable models for advanced colorectal neoplasms in screen-eligible individuals at low-to-moderate risk of colorectal cancer: towards improving colonoscopy prioritization.
Murthy SK; Antonova L; Dube C; Benchimol EI; Le Gal G; Hae R; Burke S; Ramsay T; Rostom A
BMC Gastroenterol; 2021 Oct; 21(1):383. PubMed ID: 34663234
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Characterization of Peritoneal Mesotheliomas.
Offin M; Yang SR; Egger J; Jayakumaran G; Spencer RS; Lopardo J; Nash GM; Cercek A; Travis WD; Kris MG; Ladanyi M; Sauter JL; Zauderer MG
J Thorac Oncol; 2022 Mar; 17(3):455-460. PubMed ID: 34648949
[TBL] [Abstract] [Full Text] [Related]
14. The classification capability of the Asia Pacific colorectal Screening score in Korea: an analysis of the cancer Screenee Cohort.
Luu XQ; Lee K; Kim J; Sohn DK; Shin A; Choi KS
Epidemiol Health; 2021; 43():e2021069. PubMed ID: 34607403
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of multiple statistical models for the development of clinical prediction scores to detect advanced colorectal neoplasms in asymptomatic Thai patients.
Soonklang K; Siribumrungwong B; Siripongpreeda B; Auewarakul C
Medicine (Baltimore); 2021 May; 100(20):e26065. PubMed ID: 34011125
[TBL] [Abstract] [Full Text] [Related]
16. Comparative effectiveness of five fecal immunochemical tests using colonoscopy as the gold standard: study protocol.
Levy BT; Daly JM; Xu Y; Crockett SD; Hoffman RM; Dawson JD; Parang K; Shokar NK; Reuland DS; Zuckerman MJ; Levin A
Contemp Clin Trials; 2021 Jul; 106():106430. PubMed ID: 33974994
[TBL] [Abstract] [Full Text] [Related]
17. Risk Stratification Score Improves Sensitivity for Advanced colorectal Neoplasia in colorectal cancer Screening: The Oshima Study Workgroup.
Sekiguchi M; Kakugawa Y; Ikematsu H; Hotta K; Konda K; Tanaka Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Imai K; Ito S; Koga Y; Iwasaki M; Murakami Y; Matsuda T
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00319. PubMed ID: 33939384
[TBL] [Abstract] [Full Text] [Related]
18. Risk of metachronous neoplastic lesions during post-polypectomy surveillance in individuals with advanced colorectal neoplasia at initial screening colonoscopy.
Sekiguchi M; Kakugawa Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Matsuda T
J Gastroenterol Hepatol; 2021 Aug; 36(8):2230-2238. PubMed ID: 33626598
[TBL] [Abstract] [Full Text] [Related]
19. Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance.
Usman RM; Razzaq F; Akbar A; Farooqui AA; Iftikhar A; Latif A; Hassan H; Zhao J; Carew JS; Nawrocki ST; Anwer F
Asia Pac J Clin Oncol; 2021 Jun; 17(3):193-208. PubMed ID: 32970929
[TBL] [Abstract] [Full Text] [Related]
20. Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review.
Gómez-Izquierdo J; Filion KB; Boivin JF; Azoulay L; Pollak M; Yu OHY
BMC Endocr Disord; 2020 Jun; 20(1):83. PubMed ID: 32517676
[TBL] [Abstract] [Full Text] [Related]
[Next]
